Eu hospital covid-19 experts patient Eu

Remdesivir gets lukewarm endorsement from experts in Covid fight

Reading now: 656
www.livemint.com

Covid-19 and is already being used in clinical practice. The European Commission signed a 63 million-euro ($74 million) contract with Gilead this week for batches of the drug to be made available in European Union countries from early August.Remdesivir may be effective in reducing recovery time in patients with severe Covid-19, though more trials are needed to confirm this, the experts said.

The drug probably has no important effect on the need for mechanical ventilation and may have little or no effect on the length of hospital stay.Gilead said in June that it will charge U.S.

hospitals roughly $3,120 for a course of treatment of remdesivir for most patients. The drug received an emergency use authorization from U.S.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA